Skip to main content

Sight Sciences, Inc.

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

SGHT$10.75-2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

(in thousands, except share data)

Common Stock · AdditionalPaid-In · Accumulated · TotalStockholders’
SharesAmountCapitalDeficitEquity
Balance at December 31, 202450,937,999$51$433,769$(346,297)$87,523
Issuance of common stock upon exercise of stock options35,168—63—63
Issuance of common stock upon vesting of restricted stock units403,584————
Withholding taxes on net share settlement of restricted stock units——(47)—(47)
Stock-based compensation expense——4,243—4,243
Net loss———(14,154)(14,154)
Balance at March 31, 202551,376,75151438,028(360,451)77,628
Common Stock · AdditionalPaid-In · Accumulated · TotalStockholders’
SharesAmountCapitalDeficitEquity
Balance at December 31, 202349,131,363$49$414,956$(294,790)$120,215
Issuance of common stock upon exercise of stock options132,958—145—145
Issuance of common stock upon vesting of restricted stock units300,8791(1)——
Warrant issuance——609—609
Stock-based compensation expense——4,506—4,506
Net loss———(16,266)(16,266)
Balance at March 31, 202449,565,20050420,215(311,056)109,209
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.